Hemorrhagic stroke antithrombotic drugs
Alvarez-Sabín, J.
Revista de Neurologia 32(9): 848-850
2001
ISSN/ISBN: 0210-0010 PMID: 12803195 Document Number: 537440
Document emailed within 1 workday
Related Documents
Stiefelhagen, P. 2013: Your patient needs antithrombotic drugs, 7. Averting the risk of stroke: with whom and how? MMW Fortschritte der Medizin 155(13): 24DiMinno, G.; Silver, M.J. 1983: Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol Journal of Pharmacology and Experimental Therapeutics 225(1): 57-60
Verstraete, M. 1997: Direct thrombin inhibitors: appraisal of the antithrombotic/hemorrhagic balance Thrombosis and Haemostasis 78(1): 357-363
Uchiyama, S. 2006: Antithrombotic therapy in acute ischemic stroke Rinsho Shinkeigaku 46(11): 844-846
Poungvarin, N.; Ketsa-Ard, K. 1989: Low dose aspirin and its antithrombotic effect in ischaemic stroke patient Journal of the Medical Association of Thailand 72(8): 421-426
Chen, S.-H.; Lee, H.-C.; Chang, K.-C.; Hung, J.-W.; Chen, H.-M.; Wu, C.-Y.; Yang, C.-L.; Huang, Y.-C.; Wang, H.-H. 2019: Low Persistence of Antithrombotic Agents is Associated with Poor Outcomes after First-ever Acute Ischemic Stroke Acta Neurologica Taiwanica 28(4): 95-118
Po, H.L.; Lin, Y-Ju.; Hseuh, I-Hung. 2009: The prescribing patterns of antithrombotic agents for prevention of recurrent ischemic stroke Acta Neurologica Taiwanica 18(2): 98-103
Yaghy, M.; Murin, J.; Pernicky, M.; Pekarovicova, Z.; Mikes, P. 2008: Antithrombotic treatment in patients with atrial fibrillation as a risk factor of stroke Bratislavske Lekarske Listy 109(3): 133-140
Gudkova, V.V.; Stakhovskaia, L.V.; Shanina, T.V.; Meshkova, K.S.; Shekhovtsova, K.V. 2011: The antithrombotic treatment in the secondary prevention of ischemic stroke: strategy and tactic issues Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(11 Pt 1): 87-94
Tsuzuki, N. 2002: Clinical characteristics and antithrombotic therapy for stroke prevention in patients with atrial fibrillation Hokkaido Journal of Medical Science 77(6): 563-570
Ilić, Mš.; Kikelj, D.; Ilaš, J. 2011: Multitarget antithrombotic drugs Current Topics in Medicinal Chemistry 11(22): 2834-2848
Tufano, A.; Cerbone, A.M.; Di Minno, G. 2002: The use of antithrombotic drugs in older people Minerva Medica 93(1): 13-26
Hladovec, J. 1972: Antithrombotic drugs and experimental thrombosis Cor et Vasa 20(2): 135-141
Hidden-Lucet, F.ço. 2002: Antithrombotic drugs in atrial fibrillation La Revue du Praticien 52(12): 1324-1328
Busch, M.; Masuhr, F. 2004: Thromboprophylaxis and early antithrombotic therapy in patients with acute ischemic stroke and cerebral venous and sinus thrombosis European Journal of Medical Research 9(4): 199-206
Coeugniet, E. 1976: Drugs with antithrombotic effect: experimental study Thrombosis and Haemostasis 35(2): 495-499
Anitua, E.; Prado, R.; Orive, G. 2017: Platelet-Rich Plasma Therapy and Antithrombotic Drugs Pain Physician 20(2): E335-E336
Stiefelhagen, P. 2013: Your patient needs antithrombotic drugs, 8. Which thrombosis prevention for tumor patients? MMW Fortschritte der Medizin 155(18): 26
Compostella, L.; Russo, R.; Nascimben, L.; Prandoni, P.; Schivazappa, L. 1981: ST-segment trend in patients with acute myocardial infarction treated with antithrombotic drugs Giornale Italiano di Cardiologia 11(11): 1762-1774
Vogel, G.M.; van Amsterdam, R.G.; Zandberg, P.; van Houwelingen, P.; Kop, W.J.; van Mensvoort, F.W.; Meuleman, D.G. 1997: Two new closely related rat models with relevance to arterial thrombosis--efficacies of different antithrombotic drugs Thrombosis and Haemostasis 77(1): 183-189